Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit or (NCT04508621).

News & Events
: Investor Presentations

Investor Presentations

Investor Presentation

Uploaded: Jan 11, 2021
Type: Pdf

3rd Annual Neuropsychiatric Drug Development Summit Presentation

Uploaded: Nov 12, 2020
Type: Pdf

Genetic and Engineering News Symposium Presentation

Uploaded: May 16, 2020
Type: Pdf